Detalles de la búsqueda
1.
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial.
Cancer
; 126(22): 4859-4866, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32910476
2.
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
Mod Pathol
; 32(1): 59-69, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30143750
3.
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).
Breast Cancer Res Treat
; 164(3): 571-580, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28484925
4.
Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.
Breast Cancer Res Treat
; 149(2): 439-48, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25552364
5.
Plasma versus tissue tumor mutational burden as biomarkers of durvalumab plus tremelimumab response in patients with metastatic colorectal cancer in the CO.26 trial.
Clin Cancer Res
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727700
6.
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
J Clin Oncol
; : JCO2400835, 2024 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38824432
7.
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and BCL2 gene alterations.
Leuk Lymphoma
; 61(6): 1334-1344, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31942813
8.
Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples.
J Vis Exp
; (143)2019 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30663702
9.
Abundant expression of BMI1 in follicular lymphoma is associated with reduced overall survival.
Leuk Lymphoma
; 59(9): 2211-2219, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29251058
10.
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol
; 3(11): e172085, 2017 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28750133
11.
Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.
Clin Cancer Res
; 22(10): 2435-44, 2016 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27179112
12.
PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.
Clin Cancer Res
; 20(3): 744-53, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24218517
13.
Abundant expression of interleukin-21 receptor in follicular lymphoma cells is associated with more aggressive disease.
Leuk Lymphoma
; 54(6): 1212-20, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23098230
Resultados
1 -
13
de 13
1
Próxima >
>>